Kennedy Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.91M Buy
62,306
+24,863
+66% +$1.99M 0.08% 336
2025
Q4
$3.57M Sell
37,443
-815
-2% -$79.9K 0.08% 349
2025
Q3
$3.74M Sell
38,258
-44,620
-54% -$4.62M 0.08% 342
2025
Q2
$8.9M Sell
82,878
-9,270
-10% -$938K 0.21% 163
2025
Q1
$9.3M Sell
92,148
-7,367
-7% -$742K 0.22% 158
2024
Q4
$8.89M Buy
99,515
+20,635
+26% +$1.82M 0.2% 158
2024
Q3
$6.61M Buy
78,880
+3,591
+5% +$283K 0.15% 247
2024
Q2
$5.8M Buy
75,289
+31,187
+71% +$2.28M 0.12% 275
2024
Q1
$3.02M Buy
+44,102
New +$2.84M 0.06% 445
2016
Q1
Sell
-15,205
Closed -$280K 732
2015
Q4
$280K Hold
15,205
0.01% 720
2015
Q3
$250K Hold
15,205
0.01% 707
2015
Q2
$269K Hold
15,205
﹤0.01% 717
2015
Q1
$270K Hold
15,205
﹤0.01% 707
2014
Q4
$201K Hold
15,205
﹤0.01% 732
2014
Q3
$180K Hold
15,205
﹤0.01% 759
2014
Q2
$194K Hold
15,205
﹤0.01% 733
2014
Q1
$206K Hold
15,205
﹤0.01% 728
2013
Q4
$183K Sell
15,205
-524
-3% -$6.19K ﹤0.01% 734
2013
Q3
$185K Hold
15,729
﹤0.01% 742
2013
Q2
$146K Buy
+15,729
New +$133K ﹤0.01% 732

Other funds holding BSX

Kennedy Capital Management's BSX Position: Q1 2026 in Review

Kennedy Capital Management increased its Boston Scientific (BSX) stake by 66% in Q1 2026, buying an estimated $1.99M and bringing the position to 62,306 shares worth $3.91M. The position accounts for 0.08% of the portfolio, ranked #336.

Kennedy Capital Management first reported a position in BSX in Q2 2013 and has held it in 20 quarters since. The position peaked at $9.3M in Q1 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Kennedy Capital Management held 62,306 shares of Boston Scientific worth $3.91M as of Q1 2026.
  • Kennedy Capital Management bought 24,863 Boston Scientific shares in Q1 2026, an estimated $1.99M.
  • Boston Scientific made up 0.08% of Kennedy Capital Management's portfolio in Q1 2026, its #336 holding.
  • Kennedy Capital Management first reported a position in Boston Scientific in Q2 2013 and has held it in 20 quarters since.
  • Kennedy Capital Management's Boston Scientific position peaked at $9.3M in Q1 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Kennedy Capital Management's 13F filing for Q1 2026, filed 13 May 2026.